Rocket Pharmaceuticals, Inc.
PublicRocket Pharmaceuticals, Inc. is now publicly traded
The data on this page reflects Rocket Pharmaceuticals, Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Last Round
Early Funding
Apr 28, 2026
Total Funding Raised
$180M
Company Overview
Rocket Pharmaceuticals, Inc. is a biotechnology company that develops a pipeline of investigational genetic therapies for rare and complex disorders.
AI Layer
Non-AI
Keywords
Rocket Pharmaceuticals, Inc. Comparables
Compare Rocket Pharmaceuticals, Inc. with similar companies based on industry and business-model similarity.
No public comparables are available for Rocket Pharmaceuticals, Inc.. Request access to learn about comparables coverage.
Request accessRocket Pharmaceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 28, 2026 |
Key People
Founding team and executive leadership
Rocket Pharmaceuticals, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access